Cargando…
Author Correction: Hyperpolarised (13)C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
Autores principales: | Sushentsev, Nikita, McLean, Mary A., Warren, Anne Y., Benjamin, Arnold J. V., Brodie, Cara, Frary, Amy, Gill, Andrew B., Jones, Julia, Kaggie, Joshua D., Lamb, Benjamin W., Locke, Matthew J., Miller, Jodi L., Mills, Ian G., Priest, Andrew N., Robb, Fraser J. L., Shah, Nimish, Schulte, Rolf F., Graves, Martin J., Gnanapragasam, Vincent J., Brindle, Kevin M., Barrett, Tristan, Gallagher, Ferdia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901739/ https://www.ncbi.nlm.nih.gov/pubmed/35256616 http://dx.doi.org/10.1038/s41467-022-28979-1 |
Ejemplares similares
-
Hyperpolarised (13)C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
por: Sushentsev, Nikita, et al.
Publicado: (2022) -
The potential of hyperpolarised (13)C-MRI to target glycolytic tumour core in prostate cancer
por: Sushentsev, Nikita, et al.
Publicado: (2022) -
The use of hyperpolarised (13)C-MRI in clinical body imaging to probe cancer metabolism
por: Woitek, Ramona, et al.
Publicado: (2021) -
The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T(1) relaxometry in patients with prostate cancer
por: Sushentsev, Nikita, et al.
Publicado: (2020) -
Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
por: Lau, Doreen, et al.
Publicado: (2021)